Advertisement
AKTS vs CRDO
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AKTS is a Hold and CRDO is a Hold.
AKTS in downward trend: 10-day moving average crossed below 50-day moving average on September 16, 2026
The 10-day moving average for AKTS crossed bearishly below the 50-day moving average on September 16, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AKTS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for AKTS entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator shows that the ticker has stayed in the oversold zone for 18 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
AKTS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 15 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.733) is normal, around the industry mean (2.978). P/E Ratio (-11.428) is within average values for comparable stocks, (-0.692). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (134.267) among similar stocks. P/S Ratio (125.000) is also within normal values, averaging (438.009).
The Tickeron Price Growth Rating for this company is 50 (best 1 - 100 worst), indicating steady price growth. AKTS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 72 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AKTS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
CRDO in downward trend: 10-day moving average broke below 50-day moving average on October 15, 2026
The 10-day moving average for CRDO crossed bearishly below the 50-day moving average on October 15, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 17 of 19 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 89%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 14, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CRDO as a result. In 56 of 67 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 84%.
The Moving Average Convergence Divergence Histogram (MACD) for CRDO turned negative on October 14, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 36 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 82%.
CRDO moved below its 50-day moving average on October 12, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRDO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where CRDO's RSI Indicator exited the oversold zone, 27 of 30 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +12.24% 3-day Advance, the price is estimated to grow further. Considering data from situations where CRDO advanced for three days, in 284 of 324 cases, the price rose further within the following month. The odds of a continued upward trend are 88%.
CRDO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 230 of 250 cases where CRDO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 90%.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 33 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 50 (best 1 - 100 worst), indicating fairly steady price growth. CRDO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 79 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (11.904) is normal, around the industry mean (6.418). P/E Ratio (57.990) is within average values for comparable stocks, (23.327). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.761). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (19.342) is also within normal values, averaging (45.794).
The Tickeron PE Growth Rating for this company is 95 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CRDO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 75, placing this stock worse than average.
AKTS | ||
|---|---|---|
OUTLOOK RATING 1..100 | 51 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 15 Undervalued | |
PROFIT vs RISK RATING 1..100 | 72 | |
SMR RATING 1..100 | 94 | |
PRICE GROWTH RATING 1..100 | 50 | |
P/E GROWTH RATING 1..100 | 14 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| AKTS | CRDO | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 81% | 5 days ago 90% |
| Stochastic ODDS (%) | N/A | 1 day ago 89% |
| Momentum ODDS (%) | N/A | 1 day ago 84% |
| MACD ODDS (%) | N/A | 1 day ago 82% |
| TrendWeek ODDS (%) | 1 day ago 90% | 1 day ago 82% |
| TrendMonth ODDS (%) | 1 day ago 90% | 1 day ago 87% |
| Advances ODDS (%) | N/A | 19 days ago 88% |
| Declines ODDS (%) | 5 days ago 90% | 5 days ago 82% |
| BollingerBands ODDS (%) | 1 day ago 90% | 1 day ago 89% |
| Aroon ODDS (%) | 1 day ago 90% | 1 day ago 90% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AKTS’s FA Score shows that 2 FA rating(s) are green while CRDO’s FA Score has 1 green FA rating(s).
- AKTS’s FA Score: 2 green, 3 red.
- CRDO’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AKTS’s TA Score shows that 2 TA indicator(s) are bullish while CRDO’s TA Score has 5 bullish TA indicator(s).
- AKTS’s TA Score: 2 bullish, 3 bearish.
- CRDO’s TA Score: 5 bullish, 5 bearish.
Price Growth
AKTS (@Biotechnology) experienced а -12.86% price change this week, while CRDO (@Semiconductors) price change was -13.96% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was +1.19%. For the same industry, the average monthly price growth was -15.14%, and the average quarterly price growth was -14.97%.
The average weekly price growth across all stocks in the @Semiconductors industry was -7.18%. For the same industry, the average monthly price growth was -9.61%, and the average quarterly price growth was -0.14%.
Reported Earning Dates
AKTS is expected to report earnings on Dec 02, 2026.
CRDO is expected to report earnings on Dec 02, 2026.
Industries' Descriptions
@Biotechnology (+1.19% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
@Semiconductors (-7.18% weekly)The semiconductor industry manufacturers all chip-related products, including research and development. These chips are used in innumerable electronic devices, including computers, cell phones, smartphones, and GPSs. Intel Corporation, NVIDIA Corp., and Broadcomm are some of the prominent players in this industry. Semiconductor companies usually tend to do well during periods of healthy economic growth, thereby inducing further research and development in the industry – which in turn augurs well for productivity and growth in the economy. In the near future, demand for semiconductor products (and possibly innovation within the segment) should only expand further, with the proliferation of 5G, autonomous vehicles, IoT, and various AI-driven electronics set to herald a new, advanced chapter in the technology-driven world as we know it. With burgeoning prospects comes great competition. In 2015, SIA estimated that U.S. semiconductor industry ranks as the second most competitive U.S. industry out of 2882 U.S. industries designated manufacturers by the U.S. Census Bureau.
Advertisement
AKTS and
Correlation & Price change
A.I.dvisor tells us that AKTS and SPRY have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AKTS and SPRY's prices will move in lockstep.
| Ticker / NAME | Correlation To AKTS | 1D Price Change % | ||
|---|---|---|---|---|
| AKTS | 100% | +0.33% | ||
| SPRY - AKTS | 29% Poorly correlated | +5.22% | ||
| CRDO - AKTS | 24% Poorly correlated | +1.83% | ||
| KN - AKTS | 24% Poorly correlated | +3.40% | ||
| LITE - AKTS | 24% Poorly correlated | +1.26% | ||
| ZBRA - AKTS | 23% Poorly correlated | +1.83% | ||
More | ||||
CRDO and
Correlation & Price change
A.I.dvisor indicates that over the last year, CRDO has been loosely correlated with ALAB. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if CRDO jumps, then ALAB could also see price increases.
| Ticker / NAME | Correlation To CRDO | 1D Price Change % | ||
|---|---|---|---|---|
| CRDO | 100% | +1.83% | ||
| ALAB - CRDO | 65% Loosely correlated | +0.27% | ||
| ASX - CRDO | 60% Loosely correlated | +3.21% | ||
| CAMT - CRDO | 56% Loosely correlated | -0.41% | ||
| AMBA - CRDO | 56% Loosely correlated | +1.72% | ||
| KLAC - CRDO | 55% Loosely correlated | +0.40% | ||
More | ||||